Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
conjugated estrogens
conjugated estrogens
- Formulary Estrogen Formulary
- Non-formulary
- Therapeutic Interchange
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Premarin Intravenous | POWDER FOR INJECTION, INJECTABLE | 25 mg | ||||
| Cenestin, Enjuvia | TABLET, ORAL | synthetic 0.9 mg, synthetic 1.25 mg | ||||
| Cenestin, Enjuvia | TABLET, ORAL | synthetic 0.3 mg, synthetic 0.45 mg, synthetic 0.625 mg | ||||
| Enjuvia | TABLET, ORAL | 0.3 mg, 0.625 mg, 0.9 mg | ||||
| Premarin | TABLET, ORAL | 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg, 1.25 mg | ||||
| Cenestin | TABLET, ORAL | 0.45 mg, 0.625 mg |
VIEW MORE Estrogens
Last updated: Jun. 16, 2026
- Black Box Warning: Endometrial cancer; cardiovascular; dementia risk
- HAZ-MED: Table 1
- Formulary, Not Routinely Stocked: Premarin: 0.9 mg, 1.25 mg
All doses of conjugated estrogens (Cenestin, Enjuvia) should be interchanged to an equivalent dose of generic Premarin oral tablets on 1:1 mg basis
(Interchange exception: Convert 0.3125 mg doses to 0.3 mg to prevent tablet manipulation).
Cenestin, Enjuvia: Discontinued by manufacturers.
Reviewed: October 25, 2006
Updated: February 2026 (Therapeutic Interchange Update), May 2026 (0.3125 mg Interchange)
Estrogens, Oral Formulary Update SBAR.pdf
Hazardous Medications Updates Conjugated Estrogens and Clonazepam ODT.pdf